Previous close | 3,374.00 |
Open | 3,675.00 |
Bid | 2,940.00 x 0 |
Ask | 3,650.00 x 0 |
Day's range | 3,628.00 - 3,680.00 |
52-week range | 31.08 - 3,882.00 |
Volume | |
Avg. volume | 1,403,880 |
Market cap | 4.136B |
Beta (5Y monthly) | 0.76 |
PE ratio (TTM) | 100.89 |
EPS (TTM) | 0.36 |
Earnings date | 04 Sept 2023 |
Forward dividend & yield | 0.45 (1.35%) |
Ex-dividend date | 09 Mar 2023 |
1y target est | 3,970.36 |
The Dechra Pharmaceuticals share price has soared of late. But this writer thinks the reason for that is a timely reminder of some investing wisdom. The post The Dechra share price holds a lesson for all investors! appeared first on The Motley Fool UK.
The latest investor updates on stocks that are trending on Friday.
(Bloomberg) -- EQT AB agreed to buy UK veterinary drugmaker Dechra Pharmaceuticals Plc for a lowered price of £4.46 billion ($5.6 billion) in what is still the biggest European take-private this year.Most Read from BloombergChina Is Drilling a 10,000-Meter-Deep Hole Into the EarthAmazon Is in Talks to Offer Free Mobile Service to US Prime MembersInside the Making of Redfall, Xbox’s Latest MisfireRich Latin Americans Transform Laid-Back Madrid Into a New MiamiHedge Funds at War for Top Traders Da
Pentwater Capital Management LP - Form 8.3 - Dechra Pharmacueticals Plc
Norges Bank - Form 8.3 - Dechra Pharmaceuticals PLC
Dechra, which is in talks with private equity group EQT for a possible 4.63 billion pounds ($5.84 billion) all-cash deal, fell 8.6% in early trade. The impact from de-stocking in the United States had been longer than expected and had a material impact on the third quarter, the company said in a trading statement, but added that there were signs that it was re-bounding.
Pentwater Capital Management LP - Form 8.3 - Dechra Pharmaceuticals Plc
Jon Smith explains why a major UK stock soared in price late last week, but also why it's not a viable investment opportunity, in his opinion. The post This UK stock jumped 33% on Friday, but I’m not touching it! appeared first on The Motley Fool UK.
Ninety One UK Ltd - Form 8.3 - Dechra Pharmaceuticals Plc
Friday morning saw the Dechra Pharmaceuticals share price soar by over a third. Our writer explains why, and whether he's investing. The post Why is the Dechra Pharmaceuticals share price soaring? appeared first on The Motley Fool UK.
Dechra Pharmaceuticals (LON:DPH) has had a rough month with its share price down 7.2%. However, stock prices are...
The board of Dechra Pharmaceuticals PLC ( LON:DPH ) has announced that the dividend on 13th of April will be increased...
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When you...
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Dechra Pharmaceuticals...
It is hard to get excited after looking at Dechra Pharmaceuticals' (LON:DPH) recent performance, when its stock has...
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
Dechra Pharmaceuticals PLC's ( LON:DPH ) dividend will be increasing from last year's payment of the same period to...
Dechra Pharmaceuticals PLC ( LON:DPH ) will increase its dividend from last year's comparable payment on the 18th of...